Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Normal tissue response of combined temporal and spatial fractionation in proton minibeam radiation therapy.
Int. J. Radiat. Oncol. Biol. Phys. 109, 76-83 (2021)
Purpose: Proton minibeam radiation therapy, a spatial fractionation concept, widens the therapeutic window. By reducing normal tissue toxicities, it allows a temporally fractionated regime with high daily doses. However, an array shift between daily fractions can affect the tissue-sparing effect by decreasing the total peak-to-valley dose ratio. Therefore, combining temporal fractions with spatial fractionation raises questions about the impact of daily applied dose modulations, reirradiation accuracies, and total dose modulations. Methods and Materials: Healthy mouse ear pinnae were irradiated with 4 daily fractions of 30 Gy mean dose, applying proton pencil minibeams (pMB) of Gaussian σ = 222 μm in 3 different schemes: a 16 pMB array with a center-to-center distance of 1.8 mm irradiated the same position in all sessions (FS1) or was shifted by 0.9 mm to never hit the previously irradiated tissue in each session (FS2), or a 64 pMB array with a center-to-center distance of 0.9 mm irradiated the same position in all sessions (FS3), resulting in the same total dose distribution as FS2. Reirradiation positioning and its accuracy were obtained from image guidance using the unique vessel structure of ears. Acute toxicities (swelling, erythema, and desquamation) were evaluated for 153 days after the first fraction. Late toxicities (fibrous tissue, inflammation) were analyzed on day 153. Results: Reirradiation of highly dose-modulated arrays at a positioning accuracy of 110 ± 52 μm induced the least severe acute and late toxicities. A shift of the same array in FS2 led to significantly inducted acute toxicities, a higher otitis score, and a slight increase in fibrous tissue. FS3 led to the strongest increase in acute and late toxicities. Conclusions: The highest normal-tissue sparing is achieved after accurate reirradiation of a highly dose modulated pMB array, although high positioning accuracies are challenging in a clinical environment. Nevertheless, the same integral dose applied in highly dose-modulated fractions is superior to low daily dose-modulated fractions.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
7.038
1.717
3
9
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Radiotherapy; Volume
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
2020
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
0360-3016
e-ISSN
0360-3016
Quellenangaben
Band: 109,
Heft: 1,
Seiten: 76-83
Verlag
Elsevier
Verlagsort
Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Radiation Medicine (IRM)
Institute of Experimental Genetics (IEG)
CF Pathology & Tissue Analytics (CF-PTA)
Research Unit Analytical Pathology (AAP)
Institute of Experimental Genetics (IEG)
CF Pathology & Tissue Analytics (CF-PTA)
Research Unit Analytical Pathology (AAP)
POF Topic(s)
30203 - Molecular Targets and Therapies
30201 - Metabolic Health
30505 - New Technologies for Biomedical Discoveries
30205 - Bioengineering and Digital Health
30201 - Metabolic Health
30505 - New Technologies for Biomedical Discoveries
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Radiation Sciences
Genetics and Epidemiology
Enabling and Novel Technologies
Genetics and Epidemiology
Enabling and Novel Technologies
PSP-Element(e)
G-501300-001
G-500600-001
A-630600-001
G-500390-001
G-500600-001
A-630600-001
G-500390-001
Förderungen
Deutsche Forschungsgesellschaft Cluster of Excellence: Munich-Centre for Advanced Photonics (MAP C.3.4)
BMBF project "LET-Verbund"
BMBF project "LET-Verbund"
WOS ID
WOS:000600579400017
Scopus ID
85090729334
PubMed ID
32805301
Erfassungsdatum
2020-09-21